2021 Apr 26. pii: S2213-2198(21)00496-7. doid: 10.1016/j.jaip.2021.04.034.

Effectiveness and tolerability of personalized omalizumab treatment in patients with chronic inducible urticaria.

CHDR

Buters TP, van der Velden WAC, Abdisalaam I, van Maaren MS, van Doorn MBA